Abiopharma

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025349 <b>Size:</b> 650 KB

Financial Statements and Related Announcement: Full Yearly Results

Saba Capital Management, L.P. 🔴 sold 92.2K shares of BlackRock ESG Capital Allocation Term Trust (ECAT) at $15.52 ($1.4M) Transaction Date: Aug 27, 2026 | Filing ID: 000281

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013066 <b>Size:</b> 441 KB

(98% Neutral) CYCURION, INC. (CYCU) Announces Business Combination

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001918704-26-025348 <b>Size:</b> 618 KB

New Form 424B2 - GOLDMAN SACHS GROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001193125-26-373664 <b>Size:</b> 239 KB

(99% Neutral) NORTHPOINTE BANCSHARES INC (NPB) Files Form 8-K

Director SOLOWAY RICHARD 🔴 sold 477.0K shares (1 derivative) of NAPCO SECURITY TECHNOLOGIES, INC (NSSC) at $35.93 ($16.6M) Transaction Date: Aug 26, 2026 | Filing ID: 000004

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013065 <b>Size:</b> 246 KB

New Form 424B2 - WELLS FARGO & COMPANY/MN <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0001839882-26-042242 <b>Size:</b> 647 KB

New Form 424B2 - ROYAL BANK OF CANADA <b>Filed:</b> 2026-08-28 <b>AccNo:</b> 0000950103-26-013064 <b>Size:</b> 564 KB

Form 8.3

CRISPR Therapeutics Presents Phase 1a Data for CTX310® Demonstrating Deep and Durable ANGPTL3 Editing, Triglyceride and LDL Lowering at ESC Congress 2026

(99% Neutral) QUOIN PHARMACEUTICALS, LTD. (QNRX) Provides Update on agents for gross proceeds